The launch of HealthCare.gov will likely always be remember for the numerous glitches and flaws that bogged down enrollment and the question of who is really to blame for the poor rollout remains.
The launch of HealthCare.gov will likely always be remember for the numerous glitches and flaws that bogged down enrollment and the question of who is really to blame for the poor rollout remains. However, a new report for the Office of the Inspector General (OIG) lays a large amount of blame squarely on CMS.
The “Federal Marketplace: Inadequacies in Contract Planning and Procurement” report from OIG determined that CMS did not prepare adequately for the launch of HealthCare.gov.
“The troubled launch of the Federal Marketplace at HealthCare.gov in October 2013 raised a number of concerns, including questions about the adequacy of CMS’s planning and procurement efforts for this key project under the Affordable Care Act,” according to the report.
OIG investigators reviewed documentation from CMS for the 60 contracts made to launch the federal Marketplace and selected 6 key contracts for in-depth review. They concluded that CMS did not always meet contracting requirements, such as developing an overarching acquisition strategy or performing all required oversight activities, when awarding contracts for the Marketplace.
OIG made 6 recommendations, all of with which HHS and CMS concurred:
“The complexity of the Federal Marketplace underscored the need for CMS to select the most qualified contractors,” the investigators wrote. “However, CMS did not perform thorough reviews of contractor past performance when awarding two key contracts.”
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More